Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 15599
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (84)
Results: 1-50 | Export
  1. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-14
    Posted: 2024-06-15
    Designated public office holders:
    • Tom Kmiec, Member of Parliament, Calgary Shephard | House of Commons
    Subject matters:
    • Industry
    • Health
      •
  2. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-14
    Posted: 2024-06-15
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
      •
  3. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-14
    Posted: 2024-06-15
    Designated public office holders:
    • Pam Damoff, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
      •
  4. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-13
    Posted: 2024-06-15
    Designated public office holders:
    • Julie Fielder, Special Assistant to MP Kmiec | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  5. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-07
    Posted: 2024-06-15
    Designated public office holders:
    • Tom Kmiec, Member of Parliament, Calgary Shephard | House of Commons
    • Julie Fielder, Special Assistant to MP Kmiec | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  6. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-07
    Posted: 2024-06-15
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
      •
  7. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-05-07
    Posted: 2024-06-15
    Designated public office holders:
    • Benjamin Wiles, Special Assistant to MP Damoff | House of Commons
    • Pam Damoff, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  8. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-29
    Posted: 2024-03-15
    Designated public office holders:
    • Rachel Blaney, Member of Parliament North Island Powell River | House of Commons
    Subject matters:
    • Research and Development
    • Health
      •
  9. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-29
    Posted: 2024-03-15
    Designated public office holders:
    • Tom Kmiec, Member of Parliament, Calgary Shephard | House of Commons
    Subject matters:
    • Science and Technology
    • Industry
    • Health
      •
  10. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-29
    Posted: 2024-03-15
    Designated public office holders:
    • Francesco Sorbara, Member of Parliment | House of Commons
    Subject matters:
    • Industry
    • Research and Development
    • Health
      •
  11. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-07
    Posted: 2024-01-11
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
      •
  12. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-08
    Posted: 2023-12-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Sous-ministre | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Industry
    • Health
      •
  13. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Gurjiven Sandhu, Director of Policy | Pacific Economic Development Canada (PacifiCan)
    • Jessica La Forge, Policy Advisor | Pacific Economic Development Canada (PacifiCan)
    Subject matters:
    • Science and Technology
    • Health
      •
  14. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Francesco Sorbara, Member of Parliment | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  15. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Chandra Arya, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  16. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  17. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-09-20
    Posted: 2023-10-16
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Christopher Johnstone, Assistant Deputy minister | Health Canada (HC)
    • Simon Kennedy, Sous-ministre | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
    • Research and Development
      •
  18. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-17
    Posted: 2023-09-15
    Designated public office holders:
    • Mark Holland, Minister of Health | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Health
      •
  19. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-23
    Posted: 2023-06-28
    Designated public office holders:
    • Jocelyne Voisin, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
      •
  20. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-22
    Posted: 2023-07-15
    Designated public office holders:
    • Jean-Sébastien Bock, Director of Policy, Minister's Office | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Industry
    • Science and Technology
    • Health
    • Research and Development
      •
  21. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-06
    Posted: 2023-07-15
    Designated public office holders:
    • Andy Fillmore, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Science and Technology
    • Industry
      •
  22. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Jocelyne Voisin, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Health
    • Industry
      •
  23. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Bianca Hossain, Policy advisor, Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Research and Development
    • Science and Technology
    • Health
      •
  24. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-24
    Posted: 2023-05-15
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Industry
      •
  25. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-05
    Posted: 2023-05-15
    Designated public office holders:
    • Andy Fillmore, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Industry
    • Health
    • Research and Development
      •
  26. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-03-10
    Posted: 2023-04-15
    Designated public office holders:
    • Bianca Hossain, Policy advisor, Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Jaxson Khan, Policy Advisor, Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Pierre-Yves Bourque, Director of Operations, Ministers Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Health
      •
  27. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-01-10
    Posted: 2023-02-15
    Designated public office holders:
    • Chris Zou, Policy Advisor, Office of Minister International Trade | Global Affairs Canada (GAC)
    Subject matters:
    • Health
    • Science and Technology
      •
  28. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-01-04
    Posted: 2023-02-15
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Research and Development
      •
  29. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-23
    Posted: 2022-12-15
    Designated public office holders:
    • Camille Benoit-Blouin, Special Assistant, Policy, Minister's Office International Trade, Export Promotion, Small Business and Economic Development | Global Affairs Canada (GAC)
    • Jessie Pierre, Director of Policy, Ministers office | Federal Economic Development Agency for Southern Ontario (FedDev)
    • Ashley Wright, Chief of Staff to the Minister, Minister's Office | Pacific Economic Development Canada (PacifiCan)
    • Chris Zou, Policy Advisor, Office of the Minister of International Trade, Export Promotion, Small Business and Economic Development | Global Affairs Canada (GAC)
    • Zachary Nixon, Chief of Staff to the Minister, Minister's Office International Trade | Global Affairs Canada (GAC)
    • Alexandre Boulé, Director Regional Affairs, Minister's Office | Canadian Heritage (PCH)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
    • Research and Development
      •
  30. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-09-29
    Posted: 2022-10-15
    Designated public office holders:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  31. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-07-21
    Posted: 2022-08-15
    Designated public office holders:
    • Seamus O'Regan, Minister of Labour | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Health
    • Industry
      •
  32. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-28
    Posted: 2022-07-04
    Designated public office holders:
    • Simon Kennedy, Sous-ministre | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
    • International Trade
    • Science and Technology
    • Intellectual Property
      •
  33. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-17
    Posted: 2022-07-04
    Designated public office holders:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    • Stephen Lucas, Sous-ministre, Health Products and food branch | Health Canada (HC)
    Subject matters:
    • International Trade
    • Science and Technology
    • Health
    • Industry
    • Intellectual Property
      •
  34. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-05
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  35. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-05
    Designated public office holders:
    • Adam Van Koeverden, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  36. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-05
    Designated public office holders:
    • Luc Berthold, Député | House of Commons
    • Richard Lehoux, Member of Parliament | House of Commons
    • Richard Martel, Member of Parliament | House of Commons
    • Jacques Gourde, Member of Parliament | House of Commons
    • Bernard Genereux, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  37. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-05
    Designated public office holders:
    • Alexandre Boulerice, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
      •
  38. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-05
    Designated public office holders:
    • Karl Sasseville, Deputy Chief of Staff, Minister's Office | Health Canada (HC)
    • Jean-Sébastien Bock, Director of Policy, Minister's Office | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  39. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-30
    Posted: 2022-06-08
    Designated public office holders:
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Science and Technology
    • Health
      •
  40. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-25
    Posted: 2022-03-25
    Designated public office holders:
    • Sandenga Yeba, Conseiller principal, Politiques - bureau de Quebec, Cabinet du ministre | Health Canada (HC)
    Subject matters:
    • Health
      •
  41. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-03
    Posted: 2022-04-16
    Designated public office holders:
    • Tom Kmiec, Member of Parliament, Calgary Shephard | House of Commons
    Subject matters:
    • Research and Development
    • Health
      •
  42. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-02-14
    Posted: 2022-02-14
    Designated public office holders:
    • Jean-Sébastien Bock, Directeur des politiques, Santé Canada | Health Canada (HC)
    Subject matters:
    • Health
      •
  43. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-01-27
    Posted: 2022-02-14
    Designated public office holders:
    • Luc Berthold, Député | House of Commons
    Subject matters:
    • Health
      •
  44. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-09
    Posted: 2021-12-16
    Designated public office holders:
    • Jean-Yves Duclos, Ministre de la santé, Cabinet du ministre | Health Canada (HC)
    Subject matters:
    • Health
      •
  45. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-06
    Posted: 2021-12-16
    Designated public office holders:
    • Luc Berthold, Député | House of Commons
    Subject matters:
    • Health
      •
  46. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-01
    Posted: 2021-12-03
    Designated public office holders:
    • Miro Froehlich, Policy Advisor | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Health Canada (HC)
    Subject matters:
    • Health
      •
  47. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-11-22
    Posted: 2021-12-15
    Designated public office holders:
    • Marc Miller, Minister of Indigenous Services | Indigenous Services Canada (ISC)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
      •
  48. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-11-09
    Posted: 2021-12-15
    Designated public office holders:
    • François-Philippe Champagne, Minister of Innovation Science and Industry, Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Industry
    • Health
      •
  49. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-07-07
    Posted: 2021-08-16
    Designated public office holders:
    • Erin O'Toole, Member of Parliament, Official Leader of the Opposition | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Industry
      •
  50. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-06-21
    Posted: 2021-07-15
    Designated public office holders:
    • Richard Martel, Member of Parliament | House of Commons
    • Erin O'Toole, Member of Parliament | House of Commons
    • Pierre Paul-Hus, Member of Parliament | House of Commons
    Subject matters:
    • Research and Development
    • Science and Technology
    • Industry
    • Health
      •
Date Modified: